Zur Kurzanzeige

Zytogenetische Charakterisierung der Glioblastomzelllinie G112 in Bezug auf tumorstammzellähnliche Eigenschaften und Strahlentherapie

dc.contributor.advisorGunawan, Bastian PD Dr.de
dc.contributor.advisorKim, Ella PD Dr.de
dc.contributor.authorRippl, Marinade
dc.date.accessioned2013-01-14T15:41:02Zde
dc.date.available2013-01-30T23:50:54Zde
dc.date.issued2013-01-09de
dc.identifier.urihttp://hdl.handle.net/11858/00-1735-0000-000D-F043-4de
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-1666
dc.format.mimetypeapplication/pdfde
dc.language.isogerde
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/de
dc.titleZytogenetische Charakterisierung der Glioblastomzelllinie G112 in Bezug auf tumorstammzellähnliche Eigenschaften und Strahlentherapiede
dc.typedoctoralThesisde
dc.title.translatedCytogenetic Characterisation Of Glioblastoma Cell Line G112 Concerning Tumor Stem Cell Like Properties And Radiotherapyde
dc.contributor.refereeGunawan, Bastian PD Dr.de
dc.date.examination2013-01-07de
dc.subject.dnb610 Medizin, Gesundheitde
dc.subject.gokZytopathologie {Medizin} (PPN619875712)de
dc.description.abstractengThe glioblastoma multiforme (GBM) is the most frequent and the most malignant brain tumor showing the highest rate of anaplasia (WHO Grade IV) (Riede and Schaefer 2001b). The prognosis is bad (Mueller 2006) despite multi-modal and evergrowing new methods of treatment (Omay and Vogelbaum 2009; Mueller 2006; Weller 2008; Fukushima et al. 2009; Tabatabai and Stupp 2010). Many hypotheses about the origin of GBM are being discussed (Reya et al. 2001). The “GBM-Stem-Cell-Modelde
dc.contributor.coRefereeHaase, Detlef Prof. Dr.de
dc.contributor.thirdRefereeVirsik-Köpp, Patricia Prof. Dr.de
dc.subject.topicMedicinede
dc.subject.gerGlioblastoma multiformede
dc.subject.gerZelllinie G112de
dc.subject.gerTumorstammzellhypothesede
dc.subject.gerStrahlentherapiede
dc.subject.gerZellkulturde
dc.subject.gerChromosomenanalysede
dc.subject.engGlioblastoma multiformede
dc.subject.engCell-line G112de
dc.subject.engBrain Tumor Initiating Cellsde
dc.subject.engRadiotherapyde
dc.subject.engCell culturede
dc.subject.engCytogenetical Differencesde
dc.subject.bk44.47de
dc.identifier.urnurn:nbn:de:gbv:7-webdoc-3859-4de
dc.identifier.purlwebdoc-3859de
dc.affiliation.instituteMedizinische Fakultätde
dc.identifier.ppn737345608de


Dateien

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige